Revlimid

Product NDC: 59572-415
11-digit product format: 595720415
Labeler code: 59572
Product ID: 59572-415_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lenalidomide
Dosage form: CAPSULE
Route: ORAL
Labeler: Celgene Corporation
Application: NDA021880
Marketing category: NDA
Marketing start: 2006-06-29
Substance: LENALIDOMIDE
Active strength: 15 mg/1
Pharmacologic classes: Thalidomide Analog [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021880-001	REVLIMID	LENALIDOMIDE	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27
N021880-002	REVLIMID	LENALIDOMIDE	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27
N021880-003	REVLIMID	LENALIDOMIDE	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29
N021880-004	REVLIMID	LENALIDOMIDE	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29
N021880-005	REVLIMID	LENALIDOMIDE	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21
N021880-006	REVLIMID	LENALIDOMIDE	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-product	TE code
N021880-001	AB
N021880-002	AB
N021880-003	AB
N021880-004	AB
N021880-005	AB
N021880-006	AB

Orange Book patents#

Current patent rows page 1 of 1 · 12 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N021880-001	7465800	2027-04-27		Drug substance, Drug product
N021880-001	8741929	2028-03-08	U-1983		2014-06-17
N021880-002	7465800	2027-04-27		Drug substance, Drug product
N021880-002	8741929	2028-03-08	U-1983		2014-06-17
N021880-003	7465800	2027-04-27		Drug substance, Drug product
N021880-003	8741929	2028-03-08	U-1983		2014-06-17
N021880-004	7465800	2027-04-27		Drug substance, Drug product
N021880-004	8741929	2028-03-08	U-1983		2014-06-17
N021880-005	7465800	2027-04-27		Drug substance, Drug product	2012-01-17
N021880-005	8741929	2028-03-08	U-1983		2014-06-17
N021880-006	7465800	2027-04-27		Drug substance, Drug product
N021880-006	8741929	2028-03-08	U-1983		2014-06-17

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 12 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N021880-001	ODE-241	2026-05-28
N021880-001	ODE-245	2026-05-28
N021880-002	ODE-241	2026-05-28
N021880-002	ODE-245	2026-05-28
N021880-003	ODE-241	2026-05-28
N021880-003	ODE-245	2026-05-28
N021880-004	ODE-241	2026-05-28
N021880-004	ODE-245	2026-05-28
N021880-005	ODE-241	2026-05-28
N021880-005	ODE-245	2026-05-28
N021880-006	ODE-241	2026-05-28
N021880-006	ODE-245	2026-05-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 246 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-005	REVLIMID	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-006	REVLIMID	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-005	REVLIMID	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-006	REVLIMID	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-005	REVLIMID	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-006	REVLIMID	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-005	REVLIMID	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-006	REVLIMID	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-005	REVLIMID	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-006	REVLIMID	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-005	REVLIMID	2.5MG	CAPSULE / ORAL	AB	RLD	2011-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-006	REVLIMID	20MG	CAPSULE / ORAL	AB	RLD	2013-06-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-001	REVLIMID	5MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-002	REVLIMID	10MG	CAPSULE / ORAL	AB	RLD	2005-12-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-003	REVLIMID	15MG	CAPSULE / ORAL	AB	RLD	2006-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-004	REVLIMID	25MG	CAPSULE / ORAL	AB	RLD, RS	2006-06-29	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 198 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021880-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-006	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-006	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021880-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-006	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-006	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-005	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021880-006	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-004	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-005	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021880-006	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021880-004	AB	1	`2680178bc6a6…`

Observed Orange Book patent history#

Patent history page 1 of 74 · 2,922 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021880-001	7465800	2027-04-27		Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-001	8741929	2028-03-08	U-1983		2014-06-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-002	7465800	2027-04-27		Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-002	8741929	2028-03-08	U-1983		2014-06-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-003	7465800	2027-04-27		Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-003	8741929	2028-03-08	U-1983		2014-06-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-004	7465800	2027-04-27		Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-004	8741929	2028-03-08	U-1983		2014-06-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-005	7465800	2027-04-27		Drug substance, Drug product	2012-01-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-005	8741929	2028-03-08	U-1983		2014-06-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-006	7465800	2027-04-27		Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-006	8741929	2028-03-08	U-1983		2014-06-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-001	7465800	2027-04-27		Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-001	8741929	2028-03-08	U-1983		2014-06-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-002	7465800	2027-04-27		Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-002	8741929	2028-03-08	U-1983		2014-06-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-003	7465800	2027-04-27		Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-003	8741929	2028-03-08	U-1983		2014-06-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-004	7465800	2027-04-27		Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-004	8741929	2028-03-08	U-1983		2014-06-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-005	7465800	2027-04-27		Drug substance, Drug product	2012-01-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-005	8741929	2028-03-08	U-1983		2014-06-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-006	7465800	2027-04-27		Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-006	8741929	2028-03-08	U-1983		2014-06-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021880-001	7465800	2027-04-27		Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-001	8741929	2028-03-08	U-1983		2014-06-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-002	7465800	2027-04-27		Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-002	8741929	2028-03-08	U-1983		2014-06-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-003	7465800	2027-04-27		Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-003	8741929	2028-03-08	U-1983		2014-06-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-004	7465800	2027-04-27		Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-004	8741929	2028-03-08	U-1983		2014-06-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-005	7465800	2027-04-27		Drug substance, Drug product	2012-01-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-005	8741929	2028-03-08	U-1983		2014-06-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-006	7465800	2027-04-27		Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-006	8741929	2028-03-08	U-1983		2014-06-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-001	7465800	2027-04-27		Drug substance, Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-001	8741929	2028-03-08	U-1983		2014-06-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-002	7465800	2027-04-27		Drug substance, Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-002	8741929	2028-03-08	U-1983		2014-06-17	`fd3edfee7708…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 27 · 1,062 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021880-001	ODE-241	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-001	ODE-245	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-002	ODE-241	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-002	ODE-245	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-003	ODE-241	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-003	ODE-245	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-004	ODE-241	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-004	ODE-245	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-005	ODE-241	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-005	ODE-245	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-006	ODE-241	2026-05-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021880-006	ODE-245	2026-05-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-001	ODE-241	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-001	ODE-245	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-002	ODE-241	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-002	ODE-245	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-003	ODE-241	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-003	ODE-245	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-004	ODE-241	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-004	ODE-245	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-005	ODE-241	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-005	ODE-245	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-006	ODE-241	2026-05-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021880-006	ODE-245	2026-05-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021880-001	ODE-241	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-001	ODE-245	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-002	ODE-241	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-002	ODE-245	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-003	ODE-241	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-003	ODE-245	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-004	ODE-241	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-004	ODE-245	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-005	ODE-241	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-005	ODE-245	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-006	ODE-241	2026-05-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021880-006	ODE-245	2026-05-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-001	ODE-241	2026-05-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-001	ODE-245	2026-05-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-002	ODE-241	2026-05-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021880-002	ODE-245	2026-05-28	`fd3edfee7708…`

Additional Listing Data#

Finished product: Yes
Brand name base: Revlimid
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LENALIDOMIDE	15 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F0P408N6V4	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 12 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
602910	Internal RxNorm lookup
602912	Internal RxNorm lookup
616114	Internal RxNorm lookup
616116	Internal RxNorm lookup
643712	Internal RxNorm lookup
643714	Internal RxNorm lookup
643720	Internal RxNorm lookup
643722	Internal RxNorm lookup
1242231	Internal RxNorm lookup
1242233	Internal RxNorm lookup
1428947	Internal RxNorm lookup
1429367	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5fa97bf5-28a2-48f1-8955-f56012d296be	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ba3b6b9d-cf27-aec0-3395-500a538c6915	Product name	6	20260306

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59572-415-00	Revlimid	100 in 1 BOTTLE	CAPSULE	100		40
59572-415-21	Revlimid	21 in 1 BOTTLE	CAPSULE	21		40

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59572-415-00	EA - Each	59572-415	40a5aec3-805c-43a1-b318-d26bb0c6955d	1	2012-07-24
59572-415-21	EA - Each	59572-415	d4c84bfa-81c7-467d-a16b-fc4b517e3ecb	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LENALIDOMIDE	ACTIVE INGREDIENT	F0P408N6V4	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	20
LENALIDOMIDE	ACTIVE MOIETY	F0P408N6V4	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	20
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	20
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	20
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	20
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	20

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59572-415	REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION]	40	Current NDC, Legacy NDC, 2 package rows	20230408_5fa97bf5-28a2-48f1-8955-f56012d296be.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Revlimid	LENALIDOMIDE	Celgene Corporation	5fa97bf5-28a2-48f1-8955-f56012d296be	2023-03-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021880 application number: NDA021880 ndc (product): 59572-415

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F0P408N6V4	LENALIDOMIDE	191732-72-6	LENALIDOMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
602910	lenalidomide 10 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643712	lenalidomide 15 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1242231	lenalidomide 2.5 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1428947	lenalidomide 20 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643720	lenalidomide 25 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
602912	lenalidomide 5 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
616114	Revlimid 10 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643714	Revlimid 15 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1242233	Revlimid 2.5 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1429367	Revlimid 20 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643722	Revlimid 25 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
616116	Revlimid 5 MG Oral Capsule	PSN	5fa97bf5-28a2-48f1-8955-f56012d296be	40
616114	lenalidomide 10 MG Oral Capsule [Revlimid]	SBD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643714	lenalidomide 15 MG Oral Capsule [Revlimid]	SBD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1242233	lenalidomide 2.5 MG Oral Capsule [Revlimid]	SBD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1429367	lenalidomide 20 MG Oral Capsule [Revlimid]	SBD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643722	lenalidomide 25 MG Oral Capsule [Revlimid]	SBD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
616116	lenalidomide 5 MG Oral Capsule [Revlimid]	SBD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
602910	lenalidomide 10 MG Oral Capsule	SCD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643712	lenalidomide 15 MG Oral Capsule	SCD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1242231	lenalidomide 2.5 MG Oral Capsule	SCD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1428947	lenalidomide 20 MG Oral Capsule	SCD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643720	lenalidomide 25 MG Oral Capsule	SCD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
602912	lenalidomide 5 MG Oral Capsule	SCD	5fa97bf5-28a2-48f1-8955-f56012d296be	40
616114	Revlimid 10 MG Oral Capsule	SY	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643714	Revlimid 15 MG Oral Capsule	SY	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1242233	Revlimid 2.5 MG Oral Capsule	SY	5fa97bf5-28a2-48f1-8955-f56012d296be	40
1429367	Revlimid 20 MG Oral Capsule	SY	5fa97bf5-28a2-48f1-8955-f56012d296be	40
643722	Revlimid 25 MG Oral Capsule	SY	5fa97bf5-28a2-48f1-8955-f56012d296be	40
616116	Revlimid 5 MG Oral Capsule	SY	5fa97bf5-28a2-48f1-8955-f56012d296be	40

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
59572-415-00	59572041500	100 CAPSULE in 1 BOTTLE (59572-415-00)	100 capsule	2006-07-07	0000-00-00	No	No	Current
59572-415-21	59572041521	21 CAPSULE in 1 BOTTLE (59572-415-21)	21 capsule	2006-07-07	0000-00-00	No	No	Current